Ingevity CorporationNGVTNYSE
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank54
3Y CAGR-37.2%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-37.2%/yr
vs -18.3%/yr prior
Acceleration
-18.8pp
Decelerating
Percentile
P54
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20252.70%
2024-9.25%
2023-7.60%
202210.88%
202120.01%
2020-8.40%
201923.19%
201824.44%
2017-6.67%
20160.00%